These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 21334855)
21. Altered distribution of mGlu2 receptors in β-amyloid-affected brain regions of Alzheimer cases and aged PS2APP mice. Richards G; Messer J; Faull RL; Stadler H; Wichmann J; Huguenin P; Bohrmann B; Mutel V Brain Res; 2010 Dec; 1363():180-90. PubMed ID: 20875805 [TBL] [Abstract][Full Text] [Related]
22. Increased binding of cortical and hippocampal group II metabotropic glutamate receptors in isolation-reared mice. Kawasaki T; Ago Y; Yano K; Araki R; Washida Y; Onoe H; Chaki S; Nakazato A; Hashimoto H; Baba A; Takuma K; Matsuda T Neuropharmacology; 2011; 60(2-3):397-404. PubMed ID: 20970439 [TBL] [Abstract][Full Text] [Related]
23. Positive allosteric modulators of the metabotropic glutamate receptor subtype 2 (mGluR2). Rudd MT; McCauley JA Curr Top Med Chem; 2005; 5(9):869-84. PubMed ID: 16178732 [TBL] [Abstract][Full Text] [Related]
24. Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia. Jenko KJ; Hirvonen J; Henter ID; Anderson KB; Zoghbi SS; Hyde TM; Deep-Soboslay A; Innis RB; Kleinman JE Schizophr Res; 2012 Nov; 141(2-3):185-8. PubMed ID: 22910406 [TBL] [Abstract][Full Text] [Related]
25. 5-Hydroxytryptamine2A (5-HT2A) receptor regulation in rat prefrontal cortex: interaction of a phenethylamine hallucinogen and the metabotropic glutamate2/3 receptor agonist LY354740. Marek GJ; Wright RA; Schoepp DD Neurosci Lett; 2006 Aug; 403(3):256-60. PubMed ID: 16759803 [TBL] [Abstract][Full Text] [Related]
26. Group II metabotropic glutamate receptor modulation of DOI-induced c-fos mRNA and excitatory responses in the cerebral cortex. Zhai Y; George CA; Zhai J; Nisenbaum ES; Johnson MP; Nisenbaum LK Neuropsychopharmacology; 2003 Jan; 28(1):45-52. PubMed ID: 12496939 [TBL] [Abstract][Full Text] [Related]
27. LY-2140023, a prodrug of the group II metabotropic glutamate receptor agonist LY-404039 for the potential treatment of schizophrenia. Mezler M; Geneste H; Gault L; Marek GJ Curr Opin Investig Drugs; 2010 Jul; 11(7):833-45. PubMed ID: 20571979 [TBL] [Abstract][Full Text] [Related]
28. Positive and negative modulation of circadian activity rhythms by mGluR5 and mGluR2/3 metabotropic glutamate receptors. Gannon RL; Millan MJ Neuropharmacology; 2011; 60(2-3):209-15. PubMed ID: 20831878 [TBL] [Abstract][Full Text] [Related]
29. Effects of the mGluR2/3 agonist LY354740 on computerized tasks of attention and working memory in marmoset monkeys. Spinelli S; Ballard T; Gatti-McArthur S; Richards GJ; Kapps M; Woltering T; Wichmann J; Stadler H; Feldon J; Pryce CR Psychopharmacology (Berl); 2005 Apr; 179(1):292-302. PubMed ID: 15678362 [TBL] [Abstract][Full Text] [Related]
30. Elevated level of metabotropic glutamate receptor 2/3 in the prefrontal cortex in major depression. Feyissa AM; Woolverton WL; Miguel-Hidalgo JJ; Wang Z; Kyle PB; Hasler G; Stockmeier CA; Iyo AH; Karolewicz B Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):279-83. PubMed ID: 19945495 [TBL] [Abstract][Full Text] [Related]
31. Aberrant expression of metabotropic glutamate receptor 2 in the vulnerable neurons of Alzheimer's disease. Lee HG; Ogawa O; Zhu X; O'Neill MJ; Petersen RB; Castellani RJ; Ghanbari H; Perry G; Smith MA Acta Neuropathol; 2004 Apr; 107(4):365-71. PubMed ID: 14872255 [TBL] [Abstract][Full Text] [Related]
32. Group III metabotropic glutamate receptor agonists selectively suppress excitatory synaptic currents in the rat prefrontal cortex induced by 5-hydroxytryptamine2A receptor activation. Zhang C; Marek GJ J Pharmacol Exp Ther; 2007 Jan; 320(1):437-47. PubMed ID: 17021259 [TBL] [Abstract][Full Text] [Related]
33. Postsynaptic and presynaptic group II metabotropic glutamate receptor activation reduces neuronal excitability in rat midline paraventricular thalamic nucleus. Hermes ML; Renaud LP J Pharmacol Exp Ther; 2011 Mar; 336(3):840-9. PubMed ID: 21139059 [TBL] [Abstract][Full Text] [Related]
34. Perspectives on the mGluR2/3 agonists as a therapeutic target for schizophrenia: Still promising or a dead end? Li ML; Hu XQ; Li F; Gao WJ Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jul; 60():66-76. PubMed ID: 25724760 [TBL] [Abstract][Full Text] [Related]
38. Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment. Crook JM; Tomaskovic-Crook E; Copolov DL; Dean B Am J Psychiatry; 2001 Jun; 158(6):918-25. PubMed ID: 11384900 [TBL] [Abstract][Full Text] [Related]